Incremental capacity analysis is not magic. It is a method layer that becomes valuable when the review question is commercial: is the asset condition clean enough for the pricing, underwriting, warranty, or operating story attached to it?
It should not be sold as universal proof across every chemistry and every fleet. The buyer-safe claim is narrower and stronger: it is a leading diagnostic layer in the current lithium-ion proof stack, with especially strong relevance for LFP-first utility BESS positioning.
That is exactly why it works well inside independent due diligence, warranty review, and post-COD checks: it gives a reviewer a more defensible physical read than summary State-of-Health numbers alone.